Clinical Trial

A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients

Study acronym: iHeart_2
Recruiting
View on ClinicalTrials.gov →
Summary
This study, which is being conducted as part of a Quality Improvement (QI) Initiative at Columbia University Irving Medical Center, will test whether delivering the iHeart DepCare tool increases real world reach and adoption of depression treatment among CHD patients. As part of the QI Initiative, Clinic Navigators will administer and record (in EPIC) depression screening in advance of primary care and cardiology appointments. Eligible patients with elevated depressive symptoms will be randomized to receive usual care vs. the iHeart DepCare tool in conjunction with brief motivational, technical and navigation support per patient preference. Aim 1: To test the effect of iHeart DepCare on depression treatment optimization (primary outcome) among coronary heart disease patients with elevated depressive symptoms. Aim 2: To explore the effect of iHeart DepCare on implementation outcomes, including provider referrals, among coronary heart disease patients with elevated depressive symptoms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-29.
Trial Details
NCT Number NCT07390331
Lead Sponsor Columbia University
Collaborators: National Institute on Aging (NIA)
Conditions Depression and CVD
Enrollment 200 participants
Start Date 2026-03-03
Primary Completion 2028-05-30 (estimated)
Study Completion 2029-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-06